Please add LungLife. Should be releasing some excellent trial data in Q4.
It might be worth being a bit weary of stocks that focus on AI, as at the moment it seems like everything “AI focused” is booming, but the tide could turn very quickly as has happened with other “hypes”.
I’m basing this comment exclusively on this description online though, I don’t know anything else about the company:
Obviously not investment advice @SamanthaL, just an observation.
Sorry for the delayed response, @SamanthaL. We managed to check your request, and unfortunately, we can’t add the instrument as it’s traded on an exchange to which we don’t have access.